My Micron Stock Price Prediction for 2027 | MU Stock Prediction
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 10 Sept 2026, 11:45 UTC
- Recorded by Tahlil Plus
- 10 Sept 2026, 13:35 UTC
AI-generated source summary
The analysis focuses on Micron Technology (MU) with a price target of $1200-$1500 by the end of 2027. Current price is $1007.00. The forward P/E multiple of 5.861 is considered low, given the projected EPS estimate of $171.00 for FY2028. The analysis highlights a potential re-rating of the stock to a non-cyclical valuation, driven by increasing demand for AI-related chips and long-term supply agreements. Downside risk is identified as a potential peak in CAPEX spending. If the forward P/E multiple expands to 7, the price could reach $1197, representing a 20% upside. If it expands to 9, the price could reach $1539, a 53% upside. A P/E of 4 would imply a price of $684, a 32% downside. The key upside catalyst is the re-rating to non-cyclical. A downside catalyst is a CAPEX peak. The analysis suggests that the company's business model is evolving beyond its historical cyclical nature, supported by demand from data centers and AI infrastructure.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.